Some say he pees Propofol, and that he once proposed to a Black Welsh Mountain Sheep called Blodwen. All we know is he's called The Stinge, and that he's challenged veterinary surgeons and nurses to beat his lap time in an electronic 'reasonably priced car' at the Alstoe Animal Health stand (G40) at the London Vet Show.

Alstoe says that for legal reasons (and because it doesn't have the money), The Stinge's better known cousin from BBC's Top Gear will not be making an appearance.

However the company is able to run to a bottle of champagne for the vet or nurse that sets the best lap time each day of the show.

Niall McFerran from Alstoe said: "Believe me, the Stinge is not a fast driver, so I think it will be very easy for the first contestant to beat him/her! The real question will be who is actually fastest each day. We are looking forward to having some fun".

The Kennel Club has announced it will be launching the Veterinary Practice Guide to Dog Health, a new guide to dog health for veterinary surgeons at the BVA Congress 2010 (Sept 23rd - 25th).

According to the organisation, The Veterinary Practice Guide to Dog Health has been specially developed to provide veterinary surgeons and other practice staff with a handy, updatable resource which covers a range of topics including breed specific information for all 210 recognised pedigree breeds and the range of health testing available to breeders and owners.

The guide contains information on the Kennel Club's Accredited Breeder Scheme, which currently has around 5,300 members who commit to good breeding practice, and the Fit For Function: Fit For Life campaign which aims to ensure that all dogs are able to lead their lives to the full by ensuring that they are fit enough to fulfil the function for which they were originally developed.

The guide provides details about the reporting of operations which alter the natural conformation of a dog, and a sample form which veterinary surgeons can copy and then use to report such operations to the Kennel Club. It also contains a full set of Kennel Club information guides covering a wide range of topics and examples of Kennel Club registration certificates for dogs from both standard registrations and Kennel Club Accredited Breeders to help advise puppy owners what to expect when buying a Kennel Club-registered dog.

Other topics included in the manual are a range of Kennel Club initiatives which veterinary surgeons may find useful to pass on to their clients, such as information on the Good Citizen Dog Training Scheme, the UK's largest dog training programme, and Petlog, the UK's largest microchipping and pet reunification database.

The Kennel Club's Veterinary Advisor, Nick Blayney said: "The Kennel Club Veterinary Practice Guide to Dog Health is intended to assist veterinary surgeons and all practice staff gain information about the two hundred or more breeds of dog recognised by the Kennel Club and any related health issues.

"The Kennel Club is very aware that veterinary surgeons are keen to promote the breeding of healthy puppies, but would find it useful to obtain information about the many health tests and screening schemes available and recommended for each breed.  This manual is intended to provide detailed advice on these tests and schemes on a breed by breed basis to assist vets in helping clients to understand the different conditions which may affect individual breeds."

The guide will be made available as an A4 ring binder, with the first fifty available at the BVA Congress. Recipients will be asked to agree to a follow-up visit from one of the Kennel Club's Accredited Breeder Advisors, whose role involves inspecting the breeding premises of the scheme's members to ensure that the standards required by the scheme are kept, and also establishing relationships with veterinary surgeons around the country. There are currently 14 Kennel Club Accredited Breeder Advisors across the UK and they will also be responsible for distributing the remaining copies to veterinary surgeries in the future.

Alongside the launch of the guide, a new dedicated area for veterinary surgeons has been added to the Kennel Club website at www.thekennelclub.org.uk/vets. This will include links to many of the subjects contained in the manual, and will initially feature the top 20 breeds registered in the UK. Future updated content will be added to the website as it becomes available, and the manual will subsequently be produced as a computer disk for wider distribution and convenience.

Veterinary surgeons who are not attending this year's BVA Congress, but wish to obtain a copy of the Veterinary Practice Guide to Dog Health, should visit the new section of the website and complete the request form. A representative of the Kennel Club's Health and Breeder Services team will then make contact to establish a suitable date and time for an Accredited Breeder Advisor to visit.

The Kennel Club Genetics Centre at the Animal Health Trust has identified a genetic mutation which causes progressive retinal atrophy (PRA) in Golden Retrievers, and developed a DNA test to identify carriers.

PRA is a retinal disease which causes loss of vision and leads to blindness. PRA cannot be treated - the most successful way to combat the inherited condition is to identify dogs that carry the mutation and develop informed breeding strategies.

The new DNA test has been developed following the identification of the mutation which causes the most common form of PRA among Golden Retrievers in Europe - known as GR_PRA1. The mutation which causes a second form of PRA is still to be identified.

Cathryn Mellersh, Head of Canine Genetics at the AHT, said: "Our research shows that this mutation is present in the UK Golden Retriever population, so it's likely that several hundred new carriers are being born each year and that Golden Retrievers are invariably going blind as a result.

"This new DNA test will enable breeders to learn whether their dogs are carriers of the mutation. This, in turn, will enable them to make better informed breeding decisions and therefore produce puppies which will not go blind as a result of this mutation."

Mike Townsend, Chairman of the Kennel Club Charitable Trust, said: "This is a real breakthrough and one which we hope will help to prevent blindness in many Golden Retrievers in the years to come. Every dog deserves to lead a healthy, happy life and it is important that we do all we can to ensure that future generations are given this opportunity. Our knowledge about inherited diseases in dogs is growing every day and the development of DNA tests such as this one allows breeders to ensure that the healthiest genes are passed down through the generations."

The DNA test for PRA follows the success of the AHT's DNA test launched last year to identify carriers of a mutation that causes primary lens luxation. This test identifies carriers in more than 12 breeds of dog, including Miniature Bull Terriers, Jack Russell Terriers, Parson Russell Terriers and Patterdale Terriers. To date more than 6,500 samples from 36 countries have been tested.

The Kennel Club Charitable Trust has committed £1.2 million to the Kennel Club Genetics Centre at the AHT, which will undertake research into approximately 25 inherited diseases over the next five years, facilitating the creation of further diagnostic tests which will improve the health and welfare of generations of dogs.

Full information on the Golden Retrievers PRA DNA test, and information on ordering sample kits, will be available from http://www.aht.org.uk/ from 15 November.

Medivet has announced the appointment of John Bower MBE BVSc MRCVS to its Panel of Enquiry set up following coverage of the company on Panorama.

Mr Bower has been President of the British Veterinary Association, the British Small Animal Veterinary Association, and the Veterinary Practice Management Association.

Mr Bower said: "Medivet is a large partnership with numerous branches and I am looking forward to helping the partners assess and review the management of their practice to eliminate the sort of incidents and situations that were alleged in the Panorama programme.  This panel will look deeply into the management and I have been convinced by the partners that they are determined to take appropriate measures where necessary."

Adi Nell, Medivet central partner and fellow member of the panel said: "We are delighted that John Bower is to be a part of our panel. John is not only an eminent vet of unquestionable ethical standing, but he set up and ran a medium-sized veterinary partnership for 38 years. His expertise will be crucial to Medivet, as the panel carries out its investigations and makes its recommendations over the next few months."

Mr Bower, who retired from general practice in 2007, is currently Veterinary Advisor to Petplan Insurance Company and a trustee of two national charities - Hearing Dogs for Deaf People and The Petplan Charitable Trust. Mr Bower was awarded the BSAVA Melton Award for meritorious contributions to Small Animal Practice in 1991, the MBE in 2010 for services to the BVA:AWF, and has authored or co-authored a number of books including Veterinary Practice Management, The Dog Owner's Veterinary Handbook and The Cat Owner's Veterinary Handbook.

Intervet/Schering-Plough Animal Health has launched the Intestinal Health Center for Poultry website (www.ihc-poultry.com), a website to keep producers, veterinarians, nutritionists, academics and students informed about this aspect of poultry production.

The company says it has published a wealth of practical, science-driven information and ideas to help producers manage costly gut diseases more effectively through vaccination, nutrition, sanitation and prudent drug use.

Marcelo Lang, global marketing director for the company's Poultry Business Unit said: "The new website lets you find virtually anything you need, quickly and easily, on specific intestinal health topics and products".

The website also offers a library of past issues of the company's Intestinal Health magazine and its predecessor, CocciForum, as well as three newsletters - Broiler Health, Layer Health and Turkey Health. In addition, the website includes an interactive feature called "Gut Reactions," where visitors can answer a frequently updated questionnaire related to intestinal health, immediately view survey results and then access links with more information on that topic. There is also a product finder to help users find Intervet/Schering-Plough Animal Health intestinal health products available in their market.

Marcelo added: "The Intestinal Health Center for Poultry is another example of Intervet/Schering-Plough Animal Health's commitment to educating the industry about this increasingly important segment of poultry health. We look forward to getting feedback on the site so that we can make it even better."

The Pet Doctors Group has announced that it will continue its New Graduate Programme for Autumn 2010, an initiative which the company says has proved successful since its launch in 2008. The aim of the scheme is to appoint new graduates to work in a selected number of its practices, spread across the South East of England.

Brodie Collins, Area Manager at Pet Doctors, will be meeting final year students at the Bristol University School of Veterinary Science, the Royal Veterinary College in London and the University of Cambridge Veterinary School during February and March 2010 to promote the scheme and explain the firm's approach to supporting graduates during their critical first year in practice. Successful applicants will be shortlisted by August 2010 with appointments made by September.

With the economic climate causing many practices to postpone recruitment or reduce support and training for new qualified graduates, competition for places on schemes such as this is expected to be high this year.

Brodie said: "The first twelve months out of vet school can be the most daunting of a vet's career. They're suddenly thrust into a public facing role with little experience of communicating with clients or making a diagnosis. Many have limited surgical experience and even fewer have business acumen. They really need structured support and training to build their confidence and enable them to perform effectively both from a clinical and a business perspective. Mentoring is a key support tool so our graduates are all placed with practices where this can be provided regularly.

Feedback from our scheme last year showed that what the graduates we recruited most valued was working within a team which encouraged them to be open and honest so that they could readily ask for advice and help when they needed it.  We're all individuals and perform much better if we feel comfortable with the people we're working with.  Our scheme enables us to build on our graduates'  strengths and support them in areas which they find more challenging.

We provide clinical and surgical training but also focus on the development of communication and management skills to help graduates fulfil their role as part of a business team.  The graduates we appoint will each spend their first year based within one of our smaller practices, working as part of a small and closely knit team.  At the end of the first year, if all is going well, they will have the option to stay on and help grow that practice.

In addition to veterinary skills, we're looking for graduates with a good personality fit, a strong work ethic, a caring approach and ideally some level of business understanding."

For further information on the scheme, please contact Brodie at Brodie@petdoctors.co.uk

Genitrix is encouraging practices to capitalise on the growing market opportunity for dental treatments by offering a free pack of its Dentagen Dental Wax and a special offer of six products for the price of five for the rest of its Dentagen dental range during March 2010. 

The company is also urging practices to declare March 'Dental Care Month' and to use it as a platform to step up the education they offer to pet owners on this important welfare issue.

According to Genitrix, the Dentagen range uses a plant extract called RF2 which operates as an 'anti-biofilm' treatment, modifying the membrane of oral bacteria to prevent them from producing plaque even at low concentrations. Dentagen Wax is applied to dogs or cats at the end of dental procedures in practice, while the animal is still sedated. It forms a protective coating over the teeth, which lasts for several days.

Each pack of wax contains five syringes enabling practices to offer free wax applications to pets during Dental Care Month. Pet owners can then maintain the protective coating by giving their pet either Dentagen plaque prevention chews every other day or the Dentagen Aqua drinking water additive.

For dogs, the chews are supplied in two sizes with the larger size designed for dogs over 8 kg and a smaller size for dogs less than 8 kg. Dentagen Aqua is a drinking water additive containing RF2. The company says the palatable liquid, which is added to a pet's drinking water, has proved particularly effective in treating cats which don't respond well to tooth-brushing or dental chews.

Rob Watkins, Genitrix' marketing director said: "It's well known that dental disease affects 80% of pets over three years' old and, if left untreated, can go on to cause serious health problems.  

"Data from veterinary practices also confirms that many of them are not achieving the revenue they could from offering dental treatments to their clients. We want them to get their teeth into this important revenue opportunity so we're calling on practices to make March 'Dental Care Month' and are offering them a special deal on Dentagen products to get them started.

"The efficacy of the Dentagen range in inhibiting plaque formation has been proven in clinical trials and it has proved popular with pet owners, increasing their compliance with preventative health regimes."

To order your free pack of Dentagen Wax and to take advantage of the special offer on the rest of the range, contact Genitrix on 01403 786345 or by email at mail@genitrix.co.uk

The Disciplinary Committee of the Royal College of Veterinary Surgeons has directed that the name of a veterinary surgeon who had been practising in Essex be removed from the RCVS Register, having found him guilty of attempting to obtain medicines dishonestly.

James Alexander Lockyear, a graduate from Pretoria University in South Africa, was charged with two offences. The case was heard in his absence, although the Committee did not draw any adverse inference from this. One charge concerned his attempted purchase of steroids from a pharmacy in Colchester by dishonestly representing that the medicine was for legitimate veterinary use. The second charge related to several instances of what the Committee referred to as "inappropriate and unprofessional behaviour", including showing an offensive image to another staff member on a mobile phone, placing the testicle of a castrated dog in his mouth and the misuse of an endotracheal tube.

All of the incidents had taken place between April 2008 and September 2009, while Mr Lockyear was practising as a locum veterinary surgeon at St Runwald's Veterinary Surgery, Colchester, Essex.

The Disciplinary Committee heard evidence from a pharmacist, Mr Noble, to whom Mr Lockyear had presented an incomplete veterinary prescription for 12 ampoules of Sustanon, a prescription-only anabolic steroid for humans, and a further pharmacist, Mr Foskett MRPharmS, who outlined his suspicions that the steroids were in fact for Mr Lockyear's personal use (Sustanon is a substance which can potentially be misused in relation to body-building). Mr Lockyear had originally claimed the drugs were for general stock at the practice; he later returned with a second prescription, for double the amount of Sustanon, claiming it was for his own dog; later again, he said the prescription was for a friend's dog.

The Committee also heard evidence from the veterinary owner of the practice, a veterinary nurse and a student veterinary nurse working in the practice team, and from Dr Maddison MRCVS, an expert on small animal clinical pharmacology. Dr Maddison informed the Committee that there was a veterinary alternative to Sustanon, so it was not necessary for that drug to have been sought by Mr Lockyear. She was also of the view that Sustanon would not have been suitable to treat the ailments for which Mr Lockyear claimed it was to be used.

The Committee found Mr Lockyear guilty of the first charge - that is attempting to obtain medicines dishonestly. Chairing the Disciplinary Committee, Mrs Alison Bruce, said: "Whilst it was a one-off incident, it is conduct which falls far short of that which is expected of a member of the profession. It involves serious dishonesty; it represents an abuse of a veterinary surgeon's authority to prescribe drugs; it is conduct which tends to undermine public trust in the profession, and the honesty of its members; it is conduct which compromised other professionals, the pharmacists involved, and undermined the trust which ought to exist between pharmacists and veterinary surgeons generally, in the important area of drug prescription." The Committee therefore directed that Mr Lockyear's name be removed from the Register.

Regarding the second charge, the Committee was most concerned about the incident relating to the dog's testicles, which it felt offended against Mr Lockyear's duty to treat with respect all animals which were his patients. Taking the three incidents as a whole, the Committee felt that Mr Lockyear should be seriously criticised for behaviour that was "unprofessional... juvenile, inappropriate, disgusting and offensive". However, they felt that the conduct was not malicious, and did not occur in the presence of a member of the public, so concluded that this did not amount to disgraceful conduct in a professional respect.

Ridgeway Research Ltd has a surplus supply of short-dated Target IgG kits on special offer.

The kits are to test for passive transfer to foals via colostrum. Each kit contains 20 tests and normally costs £74. They have been reduced to £20 to clear. The use by date is end February 2010.

If you are interested, please email jo@ridgewayresearch.co.uk, or ring 01594 530809 for further information.

The Disciplinary Committee of the Royal College of Veterinary Surgeons last week decided that a Lincolnshire-based veterinary surgeon should not be restored to the RCVS Register, having previously struck him off for disgraceful professional conduct, as it was not convinced that he accepted the seriousness of its finding.

In October 2007, Robert Morris, of Brant Broughton, near Lincoln, was removed from the Register having been found guilty of falsely certifying a horse to be fit for sale, despite knowing that it had a respiratory problem that could prejudice its use in the future by its new owners.

At the hearing, which concluded on 7 January, the Disciplinary Committee focused on several areas. On the day following the Committee's decision in October 2007, Mr Morris had falsely certified that two horses had been fully vaccinated every six months by his practice, when he did not know that this was the case. On two occasions during September and October of 2009, he had held himself out to be a veterinary surgeon, including examining, diagnosing and treating animals (horses and dogs). These issues, together with the fact that Mr Morris told the Committee that he was not fully familiar with the Twelve Principles of Certification, as set out in the RCVS Guide to Professional Conduct, led the Committee to believe that Mr Morris did not understand the seriousness of his conviction for disgraceful professional conduct.

The Committee also felt that there was a risk to future welfare of animals and protection of the public arising from Mr Morris' failure to understand the importance of certification. That he remained unfamiliar with the veterinary medicines regulations (and had been convicted at Grantham Magistrates Court on 1 November 2007 for possession of unauthorised veterinary medicinal products on 7 March 2006), was also taken as relevant in this regard.

The Committee also took into account the fact that Mr Morris had undertaken only limited continuing professional development since his removal, and it was concerned that it had not been presented with sufficient evidence to confirm Mr Morris' assertion that he no longer suffers from an alcohol problem.

Chairing the Disciplinary Committee, Mrs Alison Bruce, said: "In the light of its finding that Mr Morris does not fully understand the importance of accurate certification, nor of practising as a veterinary surgeon when he was not entitled to do so, the Committee considers that there is a risk to the future welfare of animals in the event of his name being restored to the Register."

She went on to add that in the case of veterinary surgeons continuing to work in a practice when struck off: "It is fully appreciated that veterinary practices may be owned and managed by lay people, however there must be a clear distinction between managing or working within a veterinary practice and practising veterinary medicine. It is of particular importance that any member who has been removed should recognise the difference between these activities. A member who has been removed must refrain from examining animals, making diagnoses or performing treatments, even under the direction of another veterinary surgeon, this includes giving veterinary advice."

European veterinary practitioners are to receive guidance on the appropriate use of the fluoroquinolone group of antibiotics in treating a wide range of common diseases in companion animals.

The advice has been drawn up by the REQUEST team, a multinational and multidisciplinary group of experts which met for the third time last November. Their recommendations have been designed to help ensure the continued availability of this class of antibiotics in both veterinary and human medicine.

The REQUEST initiative aims to achieve a consensus on when and how to prescribe fluoroquinolones, based on a detailed assessment of published scientific data by its panel of nine acknowledged international experts. Following earlier meetings in Lyon and Vienna they have reached a stage in this ongoing project in which they can offer specific guidance on the use of fluoroquinolones in treating three important conditions in dogs: pyoderma, bacterial diseases of the upper respiratory tract and lower urinary tract infections. They will also be offering guidance on the appropriate use of this class of antibiotics in cats to avoid the development of retinal toxicities, which may occasionally result from treatment with one particular fluoroquinolone drug, enrofloxacin.

The guidance will be presented in papers to be submitted to those scientific journals which will be easily accessible to veterinary practitioners throughout Europe. Further papers will be produced and translated into the main European languages giving guidance on fluoroquinolones use in other important bacterial conditions in dogs and cats.

In the later stages of the project, the team will be highlighting priorities for future research and will use its influence to encourage collaborative studies involving the animal health industry, practitioners, veterinary schools and other research institutions, which will validate and redefine the current recommendations. They will also advise on studies which may provide the information needed in those clinical areas where there is currently insufficient published data on which to base any practical advice, such as the use of fluoroquinolones in minor companion animal species.

The REQUEST initiative is supported by Vetoquinol, a global supplier of fluoroquinolone medicines to the veterinary community. Further support is provided by the healthcare consultancy StratAdviser Ltd, which gives assistance on methodology and other scientific matters and also guarantees the independence of the expert group.

Dorwest Herbs has highlighted research that suggests a highly rational mode of action for kelp seaweed as an aid in the treatment of obesity when used alongside a weight reduction diet. The company is asking vets and nurses to look at the evidence and consider using licensed herbal medicines to help cats and dogs lose weight naturally. To help you evaluate the product, Dorwest is giving away 50 trial packs of Kelp Seaweed Tablets.

Mary Boughton MBE, Quality Director at Dorwest Herbs and the UK's leading specialist in the formulation of veterinary herbal medicines said: "We have lots of evidence that Kelp Seaweed Tablets work as an aid in the treatment of obesity but traditional explanations were based on the effect of iodine supplementation on thyroid function as a mode of action. That just didn't hold water for us. However, in common with many conventional medicines, the mechanisms for mode of action of herbal medicines are often not known. So, it was with some excitement that we heard of research that demonstrated that fucoxanthin, a pigment found in kelp, upregulates expression of UCP1 (uncoupling protein) and produces weight loss in the same region as conventional anti-obesity drugs."

Various studies estimate pet obesity may affect 30 to 60 per cent of pets in the UK and arthritis, heart disease and diabetes are just some of the diseases that occur with increasing frequency in obese pets. The research indicates that fucoxanthin has an effect on glucose metabolism and may lower the risk of coronary heart disease in humans. Phlorotannins found in brown seaweed have also recently been indentified as interfering with both the onset and consequences of osteoarthritis. Mary Boughton points out that multiple effects are often seen when herbal treatments are used, "Herbal treatments contain thousands of plant derived chemical compounds and are known for their diverse action, as opposed to the 'magic bullet' effect seen with conventional medicines. In a condition such as obesity where we see many disruptions of normal metabolism and several co-morbid conditions, choosing a herbal treatment makes sense. Kelp Seaweed Tablets are the logical alternative."

Dorwest has prepared a fully referenced technical information sheet detailing recent scientific studies and data from herbal formularies with reference to the role of kelp seaweed in obesity management.

To help vets and nurses further evaluate Kelp Seaweed Tablets - a licensed herbal medicine - used as part of a weight management programme the company is giving away 50 FREE trial packs containing seven weeks of Kelp Seaweed Tablets for a large breed dog, a case report sheet and the technical information sheet. There is also a prize of £100 of John Lewis shopping vouchers for the most informative case report received before the end of February 2010.  There is one pack available per practice, while stocks last.

To request a technical information sheet or pack call Dorwest Herbs on 01308 897272.